The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.
ACTG Announces Launch of Clinical Trial Evaluating Novel globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Two clinical trials show how Levofloxacin, given once daily to children over six months, prevented infection in five-year-olds exposed to MDR-TB by 56 per cent and in adolescents by 45 per cent
With the next G20 Chief Science Advisors Roundtable (CSAR) scheduled to take place in Gujarat in August, insights emerging from these side events will be documented in the form of a report and shared with relevant stakeholders to enable effective discussions during the G20-CSAR meeting.